Latest Breaking News On - Neiman institute - Page 1 : vimarsana.com

Medicare Budget Neutrality Isn't Very Neutral | HealthLeaders Media

Continued Medicare Reimbursement Declines Could Threaten Access to Physicians

A new Harvey L. Neiman Health Policy Institute study found that physician reimbursement per Medicare patient decreased 2.3% between 2005 and 2021 when accountin

Continued Medicare reimbursement declines could threaten access to physicians

New Study Finds a 67% Increase in Neurovascular Imaging Use for Headache and Dizziness in the Emergency Department

New research demonstrates that the use of CT angiography (CTA) for patients with headache or dizziness increased dramatically over 5 years in the emergency depa

New Study Finds a 67% Increase in Neurovascular Imaging Use for Headache and Dizziness in the Emergency Department

New research demonstrates that the use of CT angiography (CTA) for patients with headache or dizziness increased dramatically over 5 years in the emergency depa

Harvey L. Neiman Health Policy Institute

Harvey L. Neiman Health Policy InstituteNews, press releases, and expert sources for journalists in science, medicine & business

Clinicians Lose more than they Can Expect to Gain when Challenging Insurer Payments Under the No Surprises Act

A new Harvey L. Neiman Health Policy Institute study found that clinicians who dispute insurer payments under the No Surprises Act (NSA) will typically pay fees

Clinicians Lose more than they Can Expect to Gain when Challenging Insurer Payments Under the No Surprises Act

A new Harvey L. Neiman Health Policy Institute study found that clinicians who dispute insurer payments under the No Surprises Act (NSA) will typically pay fees

American College of Radiology (ACR) Study Projects 5-fold Growth in FDA Approvals of Artificial Intelligence (AI) Imaging Products by 2035

A recently-released study from the Harvey L. Neiman Health Policy Institute (HPI) and American College of Radiology (ACR) Data Science Institute (DSI) projects that new U.S. Food and Drug Administration (FDA)-approved artificial intelligence (AI) medical imaging products will increase five-fold by 2035.

Study finds NPP-billed imaging increased 27% from 2016–2020